Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective

ABSTRACT: Despite the development of novel pharmacological treatments, cardiovascular disease morbidity and mortality remain high indicating an unmet clinical need. Viral gene therapy enables targeted delivery of therapeutic transgenes and represents an attractive platform for tackling acquired and...

Descripción completa

Detalles Bibliográficos
Autores principales: JT, Schwartze, M, Havenga, WAM, Bakker, AC, Bradshaw, SA, Nicklin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126699/
https://www.ncbi.nlm.nih.gov/pubmed/35606652
http://dx.doi.org/10.1007/s00109-022-02208-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126699/
https://www.ncbi.nlm.nih.gov/pubmed/35606652
http://dx.doi.org/10.1007/s00109-022-02208-0

Ejemplares similares